Simple Summary A lack of sensitive biomarkers hinders lung cancer detection and
monitoring, resulting in late diagnosis and missed treatment response. Liquid biopsies have …

Lung cancer is a widely occurring and deadly malignancy, with high prevalence rates in
China and across the globe. Specifically, non-small cell lung cancer (NSCLC) represents …

Simple Summary Early-stage disease non-small cell lung cancer has better outcomes than
advanced disease, but 5-year survival rates can drop to approximately 50% in cases of …

Cancer morbidity and mortality are growing rapidly worldwide and it is urgent to develop a
convenient and effective method that can identify cancer patients at an early stage and …

Cancer remains a major burden globally and the critical role of early diagnosis is self-
evident. Although various miRNA-based signatures have been developed in past decades …

The analysis of low-abundance protein molecules in human serum is reported based on
counting of the individual affinity-captured analyte on a solid sensor surface, yielding a …

In the era of histopathology-based diagnosis, the discrimination between multiple lung
cancers (MLCs) poses significant uncertainties and has thus become a clinical dilemma …

Lung cancer is an exceedingly malignant tumor reported as having the highest morbidity
and mortality of any cancer worldwide, thus posing a great threat to global health. Despite …

© Translational Lung Cancer Research. All rights reserved. Transl Lung Cancer Res 2024;
13 (1): 210-212| https://dx. doi. org/10.21037/tlcr-23-801 namely peripheral biomarkers. Both …

Simple Summary The non-invasive characteristic of liquid biopsy enables an increase in the
potential of VAF analysis in monitoring tumor progression, remission, and recurrence during …